Skip to main content
Clinical Trials/NCT02039232
NCT02039232
Completed
Not Applicable

CarboFix Pedicle Screw System

CarboFix Orthopedics Ltd.2 sites in 1 country46 target enrollmentJanuary 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Degenerative Disc Disease
Sponsor
CarboFix Orthopedics Ltd.
Enrollment
46
Locations
2
Primary Endpoint
Fusion success
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the safety and efficacy of CarboFix' Pedicle Screw System in the lumbar spine.

Registry
clinicaltrials.gov
Start Date
January 2014
End Date
February 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
CarboFix Orthopedics Ltd.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subject is 18 years old or older.
  • Confirmation that the physical examination of radiopathy, myelopathy or combination is in correlation with the affected level.
  • Lumbar CT, MRI, or myelography confirms the level of involvement is consistent with the subject's examination.
  • Informed consent given by the subject.

Exclusion Criteria

  • Subject is not eligible for fixation with market-available fixation means.
  • Familial history NF
  • Acute traumatic spinal injury with or without neurological signs.
  • Metabolic bone disease.
  • History of Paget's disease or other osteodystrophies whether acquired or congenital, including renal osteodystrophy, hyperthyroidism, hypothyroidism hyperparathyroidism, Ehrlers-Danlos-syndrome, osteogenesis imperfecta, achondroplasia, tuberculosis.
  • History of mental disorder or current psychiatric treatment.
  • Pregnancy and/or female subjects intending to become pregnant within the expected time frame of the study and/or female subjects of child bearing age who do not use conventional contraceptive methods.
  • Immune deficiency disease.
  • Infection in the location of the operative site, discitis, osteomyelitis, fever and/or leukocytosis (as diagnosed based on the results of CBC and ESR tests).
  • Treatment with drugs that may interfere with bone metabolism such as:

Outcomes

Primary Outcomes

Fusion success

Time Frame: 6 months post-operation

Study Sites (2)

Loading locations...

Similar Trials